Gene · 1672
Papers3,189
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,001 to 1,020 of 3,189
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Bromodomain and Extraterminal Protein Inhibitor, Apabetalone (RVX-208), Reduces ACE2 Expression and Attenuates SARS-Cov-2 Infection In Vitro. | Biomedicines | 2021 | 33919584 | PubTator, text mining | PubMed |
| Best Practice for De-Vulcanization of Waste Passenger Car Tire Rubber Granulate Using 2-2'-dibenzamidodiphenyldisulfide as De-Vulcanization Agent in a Twin-Screw Extruder. | Polymers (Basel) | 2021 | 33918356 | PubTator, text mining | PubMed |
| Novel brd4 inhibitors with a unique scaffold exhibit antitumor effects. | Oncol Lett | 2021 | 33907583 | PubTator, text mining | PubMed |
| Placentas associated with female neonates from pregnancies complicated by urinary tract infections have higher cAMP content and cytokines expression than males. | Am J Reprod Immunol | 2021 | 33905581 | PubTator, text mining | PubMed |
| Predicted regulatory SNPs reveal potential drug targets and novel companion diagnostics in psoriasis. | J Transl Autoimmun | 2021 | 33898962 | PubTator, text mining | PubMed |
| The BET inhibitor attenuates the inflammatory response and cell migration in human microglial HMC3 cell line. | Sci Rep | 2021 | 33893325 | PubTator, text mining | PubMed |
| Assessment of salivary pro inflammatory cytokines profile level in patients treated with labial and lingual fixed orthodontic appliances. | PLoS One | 2021 | 33886621 | PubTator, text mining | PubMed |
| Transcriptomic profiling of three-dimensional cholangiocyte spheroids long term exposed to repetitive Clonorchis sinensis excretory-secretory products. | Parasit Vectors | 2021 | 33879231 | PubTator, text mining | PubMed |
| Potential "biopeptidal" therapeutics for severe respiratory syndrome coronaviruses: a review of antiviral peptides, viral mechanisms, and prospective needs. | Appl Microbiol Biotechnol | 2021 | 33876282 | PubTator, text mining | PubMed |
| Development of Dimethylisoxazole-Attached Imidazo[1,2-a]pyridines as Potent and Selective CBP/P300 Inhibitors. | J Med Chem | 2021 | 33872011 | PubTator, text mining | PubMed |
| Post-Aire Medullary Thymic Epithelial Cells and Hassall's Corpuscles as Inducers of Tonic Pro-Inflammatory Microenvironment. | Front Immunol | 2021 | 33868260 | PubTator, text mining | PubMed |
| A novel comprehensive immune-related gene signature as a promising survival predictor for the patients with head and neck squamous cell carcinoma. | Aging (Albany NY) | 2021 | 33867351 | PubTator, text mining | PubMed |
| Discovery of 3,5-dimethylisoxazole derivatives as novel, potent inhibitors for bromodomain and extraterminal domain (BET) family. | Bioorg Med Chem | 2021 | 33862375 | PubTator, text mining | PubMed |
| General Stepwise Approach to Optimize a TR-FRET Assay for Characterizing the BRD/PROTAC/CRBN Ternary Complex. | ACS Pharmacol Transl Sci | 2021 | 33860212 | PubTator, text mining | PubMed |
| Improved methods for targeting epigenetic reader domains of acetylated and methylated lysine. | Curr Opin Chem Biol | 2021 | 33852996 | PubTator, text mining | PubMed |
| BRD4: An emerging prospective therapeutic target in glioma. | Mol Ther Oncolytics | 2021 | 33851008 | PubTator, text mining | PubMed |
| The brominated flame retardants TBECH and DPTE alter prostate growth, histology and gene expression patterns in the mouse. | Reprod Toxicol | 2021 | 33848595 | PubTator, text mining | PubMed |
| Comparative analysis of triple-negative breast cancer transcriptomics of Kenyan, African American and Caucasian Women. | Transl Oncol | 2021 | 33839593 | PubTator, text mining | PubMed |
| Cutaneous antimicrobial peptides: New "actors" in pollution related inflammatory conditions. | Redox Biol | 2021 | 33839421 | PubTator, text mining | PubMed |
| Interferon-Lambda 1 Inhibits Staphylococcus aureus Colonization in Human Primary Keratinocytes. | Front Pharmacol | 2021 | 33828484 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1672/papers?page=51